Skip to main content
. 2016 Sep 2;7(43):70185–70193. doi: 10.18632/oncotarget.11824

Figure 3. Forest plots of hazard ratios for 1-year and 2-year LRFS in patients between weekly and three weekly cisplatin chemoradiotherapy.

Figure 3

LRFS=Locoregional recurrence-free survival. CI=confidence interval, I2=index of heterogeneity.